Pathological changes in platelet histamine oxidases in atopic eczema
1993

Histamine and Enzyme Activity in Atopic Eczema

Sample size: 34 publication Evidence: moderate

Author Information

Author(s): Reinhold Kiehl, Gruia Ionescu

Primary Institution: Spezialklinik Neukirchen

Hypothesis

The study aims to evaluate the activity and cofactor levels of histamine catabolizing enzymes in platelets of atopic dermatitis patients compared to healthy controls.

Conclusion

Atopic eczema patients have reduced activities of monoamine and diamine oxidase enzymes, leading to increased plasma histamine levels.

Supporting Evidence

  • Diamine oxidase activity was significantly lower in atopic eczema patients compared to controls.
  • Monoamine oxidase activity was also reduced, but to a lesser extent.
  • Plasma histamine levels were found to be elevated in atopic eczema patients.

Takeaway

People with atopic eczema have lower levels of certain enzymes that break down histamine, which makes their histamine levels go up.

Methodology

The study involved 21 atopic eczema patients and 13 healthy controls, measuring enzyme activities and cofactor levels in platelet-rich plasma.

Limitations

The study did not evaluate the effects of potential confounding factors such as diet or environmental exposures in detail.

Participant Demographics

21 patients aged 15-44 years with atopic eczema and 13 healthy volunteers aged 1.6-39 years.

Statistical Information

P-Value

p<0.001 for diamine oxidase, p<0.05 for monoamine oxidase

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication